Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate
Ruxolitinib Phosphate

Ruxolitinib Phosphate

Price 3.6 USD ($)/ Gram

MOQ : 100 Grams

Ruxolitinib Phosphate Specification

  • Solubility
  • Ruxolitinib phosphate is soluble in water and some common organic solvents (such as DMSO or ethanol).
  • Storage
  • Room Temperature
  • EINECS No
  • 1312995-182-4
  • Melting Point
  • 84-89
  • Ph Level
  • 2.5 ~ 4.5
  • Molecular Formula
  • C17H21N6O4P
  • Shelf Life
  • 36 Months
  • Loss on Drying
  • Not more than 0.5%
  • Smell
  • Other
  • Molecular Weight
  • 404.360201 Grams (g)
  • Taste
  • Other
  • HS Code
  • 2933599099
  • Medicine Name
  • Ruxolitinib Phosphate
  • Chemical Name
  • (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
  • CAS No
  • 1092939-17-7
  • Type
  • Other
  • Grade
  • Medicine Grade
  • Usage
  • Ruxolitinib has the following main effects: 1. MPN treatment: Ruxolitinib is widely used to treat MPN, including diseases such as chronic myeloid leukemia and primary myelofibrosis. It helps control the proliferation of abnormal bone marrow cells and relieves related symptoms. 2. Rheumatoid arthritis treatment: In some RA patients, ruxolitinib can relieve arthritis symptoms and improve quality of life, especially for those who are insensitive to or intolerant of traditional anti-rheumatic drugs. The drug has performed well in clinical trials, with significant efficacy and high safety. Ruxolitinib is a drug commonly used to treat myelofibrosis, polycythemia vera, and acute graft-versus-host disease refractory to corticosteroids. Its unique mechanism of action helps patients relieve symptoms and improve quality of life, bringing good news to many patients. 1. Therapeutic effect of myelofibrosis: Myelofibrosis is a bone marrow disease characterized by the proliferation of fibroblasts in the bone marrow, accompanied by fibrin deposition and destruction of hematopoietic tissue. Ruxolitinib phosphate can reduce the fibrotic reaction by inhibiting the activity of Janus kinase, thereby alleviating the symptoms of patients with myelofibrosis and delaying the progression of the disease. 2. Therapeutic effect of polycythemia vera: Polycythemia vera, also known as primary polycythemia vera, is a myeloproliferative disease in which the patient has too many red blood cells. Ruxolitinib can regulate the hematopoietic process by affecting the proliferation and differentiation pathways of stem cells, help control the number of red blood cells, and alleviate symptoms and complications. 3. Efficacy of corticosteroid-refractory acute graft-versus-host disease: In the treatment of corticosteroid-refractory acute graft-versus-host disease, ruxolitinib phosphate can inhibit the activity of T cells, reduce immune response, reduce the rejection reaction and complications after allogeneic hematopoietic stem cell transplantation, and improve the treatment effect.
  • Purity(%)
  • 98.0% ~ 102.0%
  • Appearance
  • White to almost white powder
  • Physical Form
  • Powder
 

Ruxolitinib Phosphate Trade Information

  • Minimum Order Quantity
  • 100 Grams
  • FOB Port
  • Shanghai, Beijing, Shenzhen or Dongguan
  • Payment Terms
  • Paypal, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union
  • Supply Ability
  • 50000 Grams Per Month
  • Delivery Time
  • 5 Days
  • Sample Available
  • No
  • Sample Policy
  • If order is confirmed we will reimburse the sample cost
  • Packaging Details
  • 10g/Bag, 20g/Bag, 50g/Bag, 100g/Bag, 500g/Bag, 1kg/Bag or according to the specific requirements from customers.
  • Main Export Market(s)
  • Australia, North America, South America, Eastern Europe, Western Europe
 

About Ruxolitinib Phosphate

Ruxolitinib Phosphate is the phosphate form of Ruxolitinib, which is a tyrosine kinase inhibitor and is mainly used clinically to treat myeloproliferative neoplasms such as chronic myeloid leukemia and myelofibrosis.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in APIs And Intermediates Category

Dehydroepiandrosterone DHEA

Dehydroepiandrosterone DHEA

Price Range 152.50 - 300.00 USD ($) / Kilograms

Minimum Order Quantity : 1 Kilograms

Medicine Name : Dehydroepiandrosterone

Grade : Medicine Grade

Storage : Freezer

Levamisole Hydrochloride

Levamisole Hydrochloride

Price Range 40.00 - 150.00 USD ($) / Kilograms

Minimum Order Quantity : 1 Kilograms

Medicine Name : Levamisole Hydrochloride

Grade : Medicine Grade

Storage : Keep away from moisture

Tranexamic Acid

Tranexamic Acid

Price 58.50 USD ($) / Kilograms

Minimum Order Quantity : 1 Kilograms

Medicine Name : Tranexamic Acid

Grade : Medicine Grade

Storage : Room Temperature

Pharmaceutical Peptide Semaglutide

Pharmaceutical Peptide Semaglutide

Price 350.00 USD ($) / Pack

Minimum Order Quantity : 1 Pack

Medicine Name : Semaglutide

Grade : Medicine Grade

Storage : Freezer



arrow